Danai Dima, MD

Dr. Danai Dima is a hematologist-oncologist and clinician-researcher who specializes in multiple myeloma and other conditions caused by abnormal growth of plasma cells, including light chain amyloidosis and POEMS syndrome.

Her research focuses on outcomes of patients with multiple myeloma treated with chimeric antigen receptor T-cell therapies and novel bispecific antibodies. She is a member of the U.S. Multiple Myeloma Immunotherapy Consortium and has more than 50 peer-reviewed publications. 

Dr. Dima is a graduate of National and Kapodistrian University of Athens. She completed a residency in internal medicine at Tufts Medical Center and a fellowship in hematology and medical oncology at Cleveland Clinic. She is board-certified in hematology and internal medicine by the American Board of Internal Medicine.